Prosecution Insights
Last updated: April 19, 2026

Examiner: GANGLE, BRIAN J

Tech Center 1600 • Art Units: 1645

This examiner grants 76% of resolved cases

Performance Statistics

76.4%
Allow Rate
+16.4% vs TC avg
968
Total Applications
+15.4%
Interview Lift
971
Avg Prosecution Days
Based on 940 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
23.0%
§102 Novelty
15.0%
§103 Obviousness
36.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18114092 USES OF UROLITHINS Non-Final OA Amazentis SA
18269237 BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T CELLS Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18006385 METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18563922 METHOD OF PRODUCING BIOLOGICAL MATERIAL Non-Final OA NTT, Inc.
18566497 MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS Non-Final OA University of Virginia Patent Foundation
18562387 RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI Non-Final OA Pfizer Inc.
18253171 Composition Containing Bifidobacterium Lactis and Human Milk Oligosaccharides and Application Thereof Non-Final OA INNER MONGOLIA DAIRY TECH RES INSTITUTE CO LTD
18694632 MEDICAMENT FOR KILLING TUMOR CELLS Non-Final OA NIPPON MEDICAL SCHOOL FOUNDATION
18694444 ENZYME AGENT FOR COLLAGEN TRIPEPTIDE PRODUCTION OR CARTILAGE DEGRADATION Non-Final OA AMANO ENZYME INC.
18040402 BACTERIAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY Non-Final OA Universiteit Gent
18604772 BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS ATM-209 INHIBITING HELICOBACTER PYLORI AND APPLICATION THEREOF Non-Final OA SHENZHEN PORSHEALTH BIOENGINEERING CO., LTD.
18291001 Method for Purification of Botulinum Toxin Complex with Improved Purification Yield Non-Final OA INIBIO CO., LTD.
18576556 METHOD FOR PURIFICATION OF CLOSTRIDIUM BOTULINUM NEUROTOXIN PROTEIN DEPRIVED OF NON-TOXIN PROTEIN Non-Final OA PHARMA RESEARCH BIO CO., LTD.
18576206 BIOLOGICAL INSECTICIDE FORMULATION, FREE OF CHEMICAL PRODUCTS, FOR INSECT PEST CONTROL IN PLANTS Non-Final OA BIO INSUMOS NATIVA SPA
18023301 SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE Non-Final OA SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
18259633 IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SWINE DYSENTERY Non-Final OA HIPRA SCIENTIFIC, S.L.U.
18038032 BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA Non-Final OA lowa State University Research Foundation, Inc.
18302656 METHODS FOR TREATING AUTISM SPECTRUM DISORDER Non-Final OA Genevive, Inc.
18247857 MITOCHONDRIA COMPRISING ANTICANCER DRUG AND USE THEREOF Non-Final OA Paean Biotechnology Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month